Research and Development
Established in 1999, we strongly value the importance of nurturing a working culture of innovation.
-
20 % +of Revenue Invested in R&D
-
2,464Global Patent Applications have been Filed（As of 30 June 2025）
-
20Leading or Participating in the Development of 20 Domestic and International Standards of Medical Devices（As of August 2025）
News
LifeTech News
LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased
LifeTech Scientific Corporation, a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its unaudited consolidated results for the six months ended 30 June 2025.
2025 / 08 / 29
More Details
LifeTech News
LifeTech Scientific Corporation Announced 2024 Annual Results：Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%
LifeTech Scientific Corporation, a?company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiariesannounced?the audited consolidated results for the year ended 31 December 2024.
2025 / 03 / 28
More Details
LifeTech News
LifeTech Scientific Corporation Announced 2023 Annual Results：International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development
LifeTech Scientific Corporation (the “Company” or “Lifetech”, Stock code: 1302.HK), a?company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiaries announced?the audited consolidated results for the year ended 31 December 2023.
2024 / 04 / 02
More Details
LifeTech News
LifeTech Scientific Corporation Announced 2024 Interim Results：International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%
LifeTech Scientific Corporation (the “Company” or “LifeTech”, Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiaries (the “Group”) announced the consolidated results for the six months ended 30 June 2024 (the “Reporting Period”).
2024 / 08 / 30
More Details
LifeTech News
LifeTech Scientific Corporation（1302.HK） Announces 2023 Interim Results
LifeTech Scientific Corporation (the “Company” or “Lifetech”), a?leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced the unaudited consolidated results of the Company and its subsidiaries (collectively the “Group”) for the six months ended 30 June 2023 (the “Reporting Period”).
2023 / 08 / 30
More Details
Join Us
Becoming a globally-recognized, trustworthy and innovative
interventional medical device enterprise
Contact Us
interventional medical device enterprise
